By: C. Graux MD, PhD
The EHA congress is not only the opportunity to present or update the results of clinical trials, but it is also the occasion to present some fundamental research and to discuss certain themes that allow us rethinking the overall treatment strategy and monitoring of haematologic diseases.
(BELG J HEMATOL 2021;12(5):207-10)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
